Psoriasis is a chronic inflammatory disease affecting approximately 2% of the world’s population. The Psoriasis Knowledge Centre provides dermatologists, family medicine doctors and other healthcare professionals with relevant information including epidemiology, pathophysiology, diagnosis and more.
A treatment section reviews the established treatments available for psoriasis and considers their modes of action, available clinical data and place in the therapeutic pathway.
Also located within the Psoriasis Knowledge Centre is a dedicated educational section focusing on IL-17A in Psoriasis. This free resource is intended to provide healthcare professionals with information on the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A.
This educational resource has been developed for healthcare professionals in Europe who are involved in the care of patients with asthma.
Disease Awareness - This section provides background information regarding the impact of symptomatic asthma and potential management strategies.
RCGP-accredited CME - Within the continuing medical education (CME) activity, you can learn about physician perspectives on managing symptomatic asthma in practice. Richard Russell and Thys van der Molen discuss in four sessions:
What is asthma control: Who, why and how many?
Improving asthma control in the community
Current standard asthma treatment
Pros and cons of additional add-on treatment.
One hour towards your CPD will be rewarded upon successful completion of the evaluation questionnaire
SPIRIVA® Respimat® is approved for use in asthma in the European Union, Japan, USA and many other countries. The indication varies by country and the educational resource may contain information about medications for which indications may not be approved in your country.
The Chronic Spontaneous Urticaria (CSU) Knowledge Centre has been developed to address the current lack of early diagnosis of this condition. Urticaria is more common than previously thought and studies suggest chronic urticaria affects up to 1% of the population at any given time with CSU responsible for two-thirds of these cases.
Allergists, immunologists, dermatologists and other healthcare professionals involved in the management of CSU will find a range of content to support you in effectively diagnosing and treating the condition.
In this resource, you will find a disease overview, symposia highlights platform, video channel and additional resources including an events calendar and useful external links.
Marina Morgan,Consultant Medical Microbiologist Royal Devon and Exeter Hospital, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Case History A 73-year-old lady attended the emergency department nine hours after being bitten on the hand by a stray cat. She complained of severe pain in the wrist and the small puncture wounds seen near the wrist joint were reddened with accompanying lymphangitis and swelling.
Respiratory Medicine & Allergy: Non granuloma interstitial lung disease
Boris Lams,Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK Christopher Kosky,Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK
Case History A 27-year-old Caucasian nurse presents to hospital with a two-month history of gradually increasing dyspnoea, dry cough and a 2 kg weight loss. She was previously well.
Chronic lymphocytic leukaemia is the most common leukaemia in the Western world and generally..
... affects older populations. These updated ESMO Clinical Practice Guidelines present the latest information on CLL including the diagnosis and molecular biology of CLL and treatment strategies for early and advanced disease.
Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of..
... non-Hodgkin’s lymphomas. The updated ESMO Clinical Practice Guidelines provide information on the current management of diffuse large B-cell lymphoma including recommendations for screening and diagnosis, staging and risk assessment and stage-matched therapeutic strategies including specific recommendations for young and elderly, low-to-high risk subgroups.
After completing this module you should be able to: make a clinical diagnosis of myasthenia gravis, select appropriate diagnostic tests to confirm your diagnosis, and understand the principles of therapy...
Bedwetting resource receives mobile transformation
The Bedwetting Knowledge Centre has been given a new mobile-friendly look and feel. Users can now easily access FREE information and resources on nocturnal enuresis via their mobile and tablet devices.